Research Paper Volume 15, Issue 19 pp 10501—10523
A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer
Figure 10. Prediction of chemotherapy drug sensitivity in ESCC patients based on different clusters. Chemotherapy drug sensitivity of AICAR (A), Bosutinib (B), Gemcitabine (C), Pazopanib (D), Axitinib (E), Gefitinib (F), JNK.Inhibitor.VIII (G), Temsirolimus (H).